KOSDAQ · Healthcare · ₩305B
₩32,500-3.99%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 5.6% · as of 26.09.11
Among 15 신약 개발 peers
Quarterly Revenue Growth
“쌓아온 유전자 기술 권리가 수익으로 이어지는 단계예요.”
In the company's words · 2026 2분기 filing